Aravax’s PVX108 has received FDA Fast Track designation as the [...]

Medicus Pharma has received authorisation from the UAE Department of [...]

Verdiva Bio has dosed the first patient in a Phase [...]

Causaly has partnered with academic publisher Sage to give its [...]

Qureight has raised $20 million in a Series B financing [...]

ProMIS Neurosciences has reported six-month interim safety and biomarker data [...]

A new adhesive coating developed by researchers at Pusan National [...]

Qureight has raised $20 million in a Series B financing [...]

HAYA Therapeutics has received FDA Fast Track designation for HTX-001, [...]

Amorphical has completed patient enrolment in a Phase 2 trial [...]